[Form 4] Accenture PLC Insider Trading Activity

Rhea-AI Filing Summary

Martin Brudermueller, an Accenture plc (ACN) director, received 5 restricted share units (RSUs) under anti-dilution provisions tied to prior RSU awards to reflect Accenture's cash dividend. The reported transaction shows an execution price reference of $247.57 per share and indicates 1,128 Class A ordinary shares beneficially owned by the reporting person following the grant. The Form 4 was submitted to disclose this non-derivative acquisition and clarifies the RSUs were granted specifically to adjust awards for the company dividend.

Positive

• Transparency maintained: Director reported the RSU grant via Form 4, ensuring compliance with Section 16 disclosure requirements
• Anti-dilution protection applied: RSUs were granted to preserve the economic value of previously awarded equity following a cash dividend

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Small anti-dilution RSU grant to a director to reflect a cash dividend; routine governance disclosure with limited market impact.

The Form 4 documents a routine, administrative grant: 5 RSUs were issued under anti-dilution provisions of existing awards to account for a cash dividend. This preserves economic parity for long‑term equity awards after a dividend and is customary for companies that adjust equity awards for shareholder distributions. The size of the grant is immaterial relative to outstanding shares and does not indicate new compensation policy or unusual related-party transactions.

Securities Analyst

TL;DR: Insider received a minimal number of RSUs; change is disclosure-driven and unlikely to affect valuations.

The reported acquisition of 5 RSUs and total beneficial ownership of 1,128 shares is minor and consistent with standard anti-dilution mechanics following a cash dividend. The referenced price of $247.57 provides context for the dividend adjustment but does not represent an open-market purchase. From a securities perspective, this is a routine Section 16 disclosure that maintains transparency without signaling material insider trading or strategic shifts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brudermueller Martin

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	08/15/2025		A		5(1)	A	$247.57	1,128	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Martin Brudermueller	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for Accenture (ACN) disclose?

The Form 4 shows director Martin Brudermueller received 5 RSUs under anti-dilution provisions and now beneficially owns 1,128 Class A ordinary shares.

Why were the 5 RSUs granted to the director?

The RSUs were granted pursuant to anti-dilution provisions of previously granted awards to reflect Accenture's payment of a cash dividend.

Does the Form 4 show an open-market purchase price for ACN shares?

The filing references $247.57 in association with the reported non-derivative transaction, but the entry reflects an RSU grant due to dividend adjustment, not an open-market purchase.

How material is this insider transaction to ACN shareholders?

The grant of 5 RSUs is immaterial in size relative to total outstanding shares and is a routine adjustment, so it is unlikely to be material to shareholders.